Plain-English translation of NCT07102381 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it works better when combined with chemotherapy for people with early-stage HER2-positive breast cancer. The study will give you the medication and chemotherapy drugs before you have breast surgery, to try to shrink the cancer and improve your chances of recovery. Researchers want to know if this new combination is safe and more effective than the standard treatments currently used.
HER2-positive breast cancer is an aggressive type that grows quickly, and doctors are always looking for better treatment combinations to improve outcomes. This trial exists to see whether adding this new medication to standard chemotherapy might help more patients achieve better results before surgery.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of three treatment combinations: the new medication with one type of chemotherapy, or with a different chemotherapy combination, or standard medications with chemotherapy. You will receive these treatments over several months before having surgery to remove the breast cancer. During the study, you will visit the clinic regularly for blood tests, heart monitoring, and treatment infusions, and researchers will track how well the cancer responds to treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States